The results were further verified by flow cytometry, and IFN-γ treatment, in accordance with previous reports, upregulated the membrane expression of both MHC-I and ICAM-1 on tumour cells (Fig. 5f, g). The gene discussed is ICAM1; the disease is neoplasm.